Literature DB >> 10440973

Cognitive decline in ageing: are AAMI and AACD distinct entities?

M Richards1, J Touchon, B Ledesert, K Richie.   

Abstract

BACKGROUND: Two sets of research diagnostic criteria, age-associated memory impairment (AAMI) and ageing-associated cognitive decline (AACD), are widely used to describe mild cognitive decline in ageing. However, the extent to which the nosological entities they represent are similar or distinct is unclear.
METHODS: A sample of 111 participants without dementia but with informant evidence of cognitive decline were drawn from the EUGERIA Study of Cognitive Ageing, a population-based study in southern France. These participants were classified as either normal or with AAMI according to the criteria of Crook et al. (1986), then reclassified as normal or with AACD according to criteria recommended by Levy et al. (1994). Neuropsychological test scores were then compared in these two pairs of groups.
RESULTS: Particpants were classified as either normal (N=74) or with AAMI (N=37), then reclassified as normal (N=72) or with AACD (N=39). Only 20 (54%) of participants with AAMI simultaneously met criteria for AACD, and those with AACD showed more extensive cognitive impairment than those with AAMI.
CONCLUSIONS: Although there is a large overlap between AAMI and AACD, these findings suggest that AAMI and AACD refer to distinct clinical entities, the latter delineating a more severe state of impairment. This may be largely because AAMI is defined as impairment with reference to young normals, whereas AACD refers to impairment with respect to normal contemporaries. Copyright 1999 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  1999        PMID: 10440973     DOI: 10.1002/(sici)1099-1166(199907)14:7<534::aid-gps963>3.0.co;2-b

Source DB:  PubMed          Journal:  Int J Geriatr Psychiatry        ISSN: 0885-6230            Impact factor:   3.485


  10 in total

Review 1.  The impact of mild cognitive impairment on functional abilities in the elderly.

Authors:  Steven M Albert; Matias H Tabert; Alan Dienstag; Gregory Pelton; Devangere Devanand
Journal:  Curr Psychiatry Rep       Date:  2002-02       Impact factor: 5.285

Review 2.  Brain aging, Alzheimer's disease, and mitochondria.

Authors:  Russell H Swerdlow
Journal:  Biochim Biophys Acta       Date:  2011-09-02

3.  [Symptoms and imaging diagnostics of neurodegenerative dementia].

Authors:  P Schönknecht; C Sattler; P Toro; M Essig
Journal:  Radiologe       Date:  2011-04       Impact factor: 0.635

4.  Neuropsychological characteristics of mild cognitive impairment subgroups.

Authors:  O L Lopez; J T Becker; W J Jagust; A Fitzpatrick; M C Carlson; S T DeKosky; J Breitner; C G Lyketsos; B Jones; C Kawas; L H Kuller
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-08-15       Impact factor: 10.154

Review 5.  Cognitive experience and its effect on age-dependent cognitive decline in beagle dogs.

Authors:  Norton W Milgram
Journal:  Neurochem Res       Date:  2003-11       Impact factor: 3.996

6.  Comparison of heterogeneity quantification algorithms for brain SPECT perfusion images.

Authors:  Romain Modzelewski; Elise Janvresse; Thierry de la Rue; Pierre Vera
Journal:  EJNMMI Res       Date:  2012-07-20       Impact factor: 3.138

7.  Mild cognitive impairment: an epidemiological perspective.

Authors:  Karen Ritchie
Journal:  Dialogues Clin Neurosci       Date:  2004-12       Impact factor: 5.986

8.  Age-related mild cognitive deficit: a ready-to-use concept?

Authors:  Christian Gilles
Journal:  Dialogues Clin Neurosci       Date:  2003-03       Impact factor: 5.986

9.  Mild cognitive impairment: narrative review of taxonomies and systematic review of their prediction of incident Alzheimer's disease dementia.

Authors:  Nicholas I Bradfield; David Ames
Journal:  BJPsych Bull       Date:  2020-04

Review 10.  Mitochondrial links between brain aging and Alzheimer's disease.

Authors:  Heather M Wilkins; Russell H Swerdlow
Journal:  Transl Neurodegener       Date:  2021-09-01       Impact factor: 8.014

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.